REFERENCES
- Aggarwal, A., Schneider, S. A., Houlden, H., Silverdale, M., Paudel, R., Paisan-Ruiz, C., (2010). Indian-subcontinent NBIA: Unusual phenotypes, novel PANK2 mutations, and undetermined genetic forms. Movement Disorders, 25(10), 1424–1431.
- Baumeister, F. A., Auer, D. P., (2005). The eye-of-the-tiger sign is not a reliable disease marker for Hallervorden-Spatz syndrome. Neuropediatrics, 36(3), 221–222.
- Gregory, A., Polster, B. J., & Hayflick, S. J. (2009). Clinical and genetic delineation of neurodegeneration with brain iron accumulation. Journal of Medical Genetics, 46(2), 73–80.
- Hallervorden, J., & Spatz, H. (1922). Eigenartige Erkrankun im extrapyramidalen System mit besonderer Beteiligung des Globus pallidus und der Substantia nigra. Journal of Neurology & Psychiatry, 79, 254–302.
- Hartig, M. B., Hortnagel, K., Garavaglia, B., Zorzi, G., Kmiec, T., Klopstock, T., (2006). Genotypic and phenotypic spectrum of PANK2 mutations in patients with neurodegeneration with brain iron accumulation. Annals of Neurology, 59(2), 248–256.
- Hayflick, S. J., Westaway, S. K., Levinson, B., Zhou, B., Johnson, M. A., Ching, K. H., (2003). Genetic, clinical, and radiographic delineation of Hallervorden-Spatz syndrome. The New England Journal of Medicine, 348(1), 33–40.
- Van der Knaap, M. S., Valk, J., de Neeling, N., & Nauta, J. J. (1991). Pattern recognition in magnetic resonance imaging of white matter disorders in children and young adults. Neuroradiology, 33(6), 478–493.
- Rump, P., Lemmink, H. H., Verschuuren-Bemelmans, C. C., Grootscholten, P. M., Fock, J. M., Hayflick, S. J., (2005). A novel 3-bp deletion in the PANK2 gene of Dutch patients with pantothenate kinase-associated neurodegeneration: Evidence for a founder effect. Neurogenetics, 6(4), 201–207.
- Rutledge, J. N., Hilal, S. K., Silver, A. J., Defendini, R., & Fahn, S. (1988). Magnetic resonance imaging of dystonic states. Advances in Neurology, 50, 265–275.
- Savoiardo, M., Halliday, W. C., Nardocci, N., Strada, L., D'Incerti, L., Angelini, L., (1993). Hallervorden-Spatz disease: MR and pathologic findings. AJNR –American Journal of Neuroradiology, 14(1), 155–162.
- Seo, J. H., Song, S. K., & Lee, P. H. (2009). A novel PANK2 mutation in a patient with atypical pantothenate-kinase-associated neurodegeneration presenting with adult-onset parkinsonism. The Journal of Clinical Neurology, 5(4), 192–194.
- Song, X. W., Wang, Y. L., Shi, Y. W., Deng, W. Y., Chen, S. Q., Lin, H., (2009). Clinical manifestations and detection of pantothenate kinase 2 gene mutation in a patient with Hallervorden-Spatz syndrome. Zhonghua Yi Xue Za Zhi, 89(47), 3320–3323.
- Swaiman, K. F. (1991). Hallervorden-Spatz syndrome and brain iron metabolism. Archives of Neurology, 48(12), 1285–1293.
- Swaiman, K. F. (2001). Hallervorden-Spatz syndrome. Pediatric Neurology, 25(2), 102–108.
- Valentino, P., Annesi, G., Ciro Candiano, I. C., Annesi, F., Civitelli, D., Tarantino, P., (2006). Genetic heterogeneity in patients with pantothenate kinase-associated neurodegeneration and classic magnetic resonance imaging eye-of-the-tiger pattern. Movement Disorders, 21(2), 252–254.
- Vasconcelos, O. M., Harter, D. H., Duffy, C., McDonough, B., Seidman, J. G., Seidman, C., (2003). Adult Hallervorden-Spatz syndrome simulating amyotrophic lateral sclerosis. Muscle & Nerve, 28(1), 118–122.
- Zhang, Y. H., Tang, B. S., Zhao, A. L., Xia, K., Long, Z. G., Guo, J. F., (2005). Novel compound heterozygous mutations in the PANK2 gene in a Chinese patient with atypical pantothenate kinase-associated neurodegeneration. Movement Disorders, 20(7), 819–821.
- Zhou, B., Westaway, S. K., Levinson, B., Johnson, M. A., Gitschier, J., & Hayflick, S. J. (2001). A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome. Nature Genetics, 28(4), 345–349.